Voice Prosthesis Devices Market Size - By Product (Indwelling & Non-Indwelling Voice Prosthesis), Valve Type (Provox Valve, Blom-Singer Valve, Groningen Valve), End-use (Hospitals, Ambulatory Surgical Centers) – Global Forecast, 2024 – 2032

North America voice prosthesis devices industry accounted for USD 247.2 million revenue in 2023 and is predicted to witness substantial growth through 2032 as the region has a relatively high incidence of laryngeal cancer, alongside the presence of advanced healthcare infrastructure, including state-of-the-art hospitals, specialized treatment centers, and academic medical institutions.

Andreas Fahl Medizintechnik-Vertrieb GmbH, Atos Medical, HEIMOMED Heinze GmbH & Co. KG, Hood Laboratories, ICU Medical, Inc., InHealth Technologies, Innaumation Medical Devices Private Limited, Luminaud, Inc., Servona GmbH, and Teleflex Incorporated.

The market size of voice prosthesis devices was reached USD 579 million in 2023 and is estimated to cross over USD 1.1 billion by 2032, attributed to the ongoing advancements in medical devices and increasing prevalence of laryngeal cancer.

The hospitals segment accounted for around USD 347.9 million revenue in 2023 and will grow significantly through 2032 as these settings have advanced diagnostic imaging technologies, surgical facilities, and multidisciplinary teams of healthcare professionals capable of diagnosing and treating laryngeal disorders effectively.